BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

AP Pharma

A.P. Pharma, Inc. (NASDAQ Global Market: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems. We are focused on developing pharmaceutical products using our proprietary BiochronomerTM polymer-based drug delivery technology. Our product development philosophy is based on incorporating approved therapeutics into our proprietary bioerodible drug delivery technology to create controlled release pharmaceuticals to improve treatments for diseases or conditions. Our lead product candidate, APF530, is currently in a pivotal Phase III clinical trial for the prevention of acute and delayed onset chemotherapy-induced nausea and vomiting, or CINV. Our primary focus is to advance our proprietary Biochronomer technology, consisting of bioerodible polymers designed to release drugs over a defined period. We have completed over 100 in vivo and in vitro studies demonstrating that our Biochronomer technology is potentially applicable to a range of therapeutic areas, including pain management, prevention of nausea and vomiting, control of inflammation and treatment of ophthalmic diseases. We have also completed comprehensive animal and human toxicology studies that have established that our Biochronomer polymers are safe and well tolerated. Furthermore, our Biochronomer technology can be designed to deliver drugs over periods varying from days to several months.


Contact Details:
123 Saginaw Drive
Redwood City
94063
Tel:650-366-2626
Fax:
Email:jobs@appharma.com
WWW:

www.appharma.com/




Recent Publications by AP Pharma:

Poly(ortho esters)--from concept to reality.
The development of poly(ortho esters) dates back to the early 1970s, and...
23rd February, 2005
AP Pharma, 123 Saginaw Drive, Redwood City, California 94063, USA. Biomacromolecules. 2004 Sep-Oct;5(5):1625-32.
DOI Direct Link
Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery.
The fabrication, morphological characterization, and drug release kinetics...
23rd April, 2003
AP Pharma, Redwood City, CA 94063, USA. Biomaterials. 2002 Nov;23(22):4405-12.

BioNews Results for AP Pharma:

APDCA to recommend state govt to procure medicines from companies within AP
PharmaBiz:  Aug 29 2008 5:00AM Matching: ap pharma
Belgian drug maker UCB to shed 2,000 staff worldwide as revenues slip as patents expire
Canadian Business Magazine:  Aug 28 2008 12:30PM Matching: ap pharma
Belgian drug maker UCB to shed 2,000 staff worldwide as revenue slip on expiry of patents
Canadian Business Magazine:  Aug 28 2008 12:15PM Matching: ap pharma
Belgian drug maker UCB to shed 2,000 jobs globally
PR inside:  Aug 28 2008 11:55AM Matching: ap pharma
Bal Phrama to commission Uttarakhand facility shortly
Express Pharma:  Aug 26 2008 11:16PM Matching: ap pharma
Promote your company here: BioNewsCast - Press Release Distribution

View more AP Pharma news.

AP Pharma Patents:

US Patent No.Title
6822000 Bioerodible poly (orthoesters) from dioxolane-based diketene acetals
6790458 Pharmaceutical compositions using semi-solid delivery vehicle
6590059 Bioerodible polyorthoesters from dioxolane-based diketene acetals
6524606 Bioerodible polyorthoesters containing amine groups

AP Pharma (APPA) Financial information Links from Barchart

APPA Quote from from Barchart.com
APPA Chart from from Barchart.com
APPA Profile from from Barchart.com
APPA Opinion from from Barchart.com

View more AP Pharma finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 482 times since April 2007, the link to the organisation's website has been followed 84 times

Recent Search Terms used to find this page: Contact Details of Pharmaceutical companies in A.P | ap pharma | directory of pharmaceutical companies in A.P | AP PHARMA | amine polyorthoesters | a.p. pharma patent | bioerodible polymers uk companies | AP Pharma | AP pharma UK | APF530 PATENT | .

Search for more companies in Redwood City

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AP Pharma
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.